The antibody 34bE12, available from A Menarini Diagnostics, recognises cytokeratin 1, 5, 10 and 14. It reacts with squamous and adenosquamous cell carcinomas, while adenocarcinoma is negative. In normal tissue, 34bE12 stains stratified epithelia, myoepithelial cells and basal cells in the prostate gland and bronchus. Thus, it is useful as a differential marker for squamous carcinoma and adenocarcinoma as well as for benign and malignant tumours of the prostate gland.
Other News
Latest Issues
Benson Viscometers Ltd is a British manufacturing company that specialises in the design, development and manufacture of high quality plasma viscometers and blood measuring equipment.
Established in 1999 the family run company has established itself as the leader in the provision of Plasma Viscometers throughout the UK. The majority of the...
UK Neqas webinar - Introduction to the Theory and Practice of Histological Staining
Online
13-14 January, 2026
RSM / Path Soc 2026 Winter Meeting
The Royal Society of Medicine, 1 Wimpole St, London, W1G 0AE
20 - 21 January, 2026
BIVDA Regulatory Affairs Seminar
Grand Hotel, Birmingham
10 - 11 February, 2026
BDIAP Molecular Pathology Study Day
10 Union Street, London, SE1 1SZ
2 March, 2026
USCAP 115th Annual Meeting
Henry B. González Convention Center, San Antonio, Texas, USA
21 - 26 March, 2026